<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03037827</url>
  </required_header>
  <id_info>
    <org_study_id>A001</org_study_id>
    <nct_id>NCT03037827</nct_id>
  </id_info>
  <brief_title>The Effect of Laser Power and Fiber Traction Speed on the Outcomes of Endovenous Laser Ablation</brief_title>
  <acronym>SLEDGE</acronym>
  <official_title>Three Different Regimens of Endovenous Laser Ablation With Equal Linear Endovenous Energy Density (The SLEDGE Study): a Prospective, Randomized Multicenter Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinic of Phlebology and Laser Surgery, Chelyabinsk, Russia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medalp Private Surgery Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Garantclinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinic of Phlebology and Laser Surgery, Chelyabinsk, Russia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multicenter clinical randomized controlled trial, comparing of three different regimens of
      endovenous laser ablation with equal linear endovenous energy density in patients with
      insufficiency of the great saphenous vein (GSV). The linear endovenous energy density (LEED)
      is the main value for standardization EVLA. From many studies, it is known the optimum value
      of the LEED. However, the same LEED may be obtained by varying the ratio between the laser
      power and the fiber pullback speed. Power decrease can allow to reduce the incidence of
      adverse effects of endovenous laser ablation, but keep high efficiency.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 30, 2017</start_date>
  <completion_date type="Anticipated">December 30, 2017</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of participants with a fully obliterated target vein</measure>
    <time_frame>3 month</time_frame>
    <description>An ultrasound investigation of the treated vein to find out is the treated vein is fully obliterated or not, and to find out is there any pathological reflux in the vein.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>day 1</time_frame>
    <description>Pain (numeric rating scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>day 7</time_frame>
    <description>Pain (numeric rating scale)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of patients with adverse events</measure>
    <time_frame>3 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Paresthesia</measure>
    <time_frame>3 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Deep venous thrombosis</measure>
    <time_frame>day 7</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Superficial venous thrombosis</measure>
    <time_frame>day 7</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">750</enrollment>
  <condition>Varicose Veins</condition>
  <arm_group>
    <arm_group_label>Endovenous laser ablation (EVLA) 5W</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One of three different regimens of endovenous laser ablation, the fiber pullback speed 0.7 mm/s, laser power 5 W, LEED 71 J/cm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Endovenous laser ablation (EVLA) 7W</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One of three different regimens of endovenous laser ablation, the fiber pullback speed 1 mm/s, laser power 7 W, LEED 70 J/cm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Endovenous laser ablation (EVLA) 10W</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One of three different regimens of endovenous laser ablation, the fiber pullback speed 1.5 mm/s, laser power 10 W, LEED 67 J/cm</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endovenous laser ablation (EVLA)</intervention_name>
    <description>Endovenous laser ablation with laser wavelength 1470 nm and radial laser fiber</description>
    <arm_group_label>Endovenous laser ablation (EVLA) 5W</arm_group_label>
    <arm_group_label>Endovenous laser ablation (EVLA) 7W</arm_group_label>
    <arm_group_label>Endovenous laser ablation (EVLA) 10W</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laser</intervention_name>
    <description>Device for endovenous laser ablation manufactured by Biolitec AG company (ELVeS system) - diode laser with a wavelength of 1470 nm</description>
    <arm_group_label>Endovenous laser ablation (EVLA) 5W</arm_group_label>
    <arm_group_label>Endovenous laser ablation (EVLA) 7W</arm_group_label>
    <arm_group_label>Endovenous laser ablation (EVLA) 10W</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients over 18 years old Insufficiency of the GSV measured with ultrasound imaging,
        reflux &gt; 0.5 sec No prior treatment of the insufficient GSV Informed consent

        Exclusion Criteria:

        Acute deep or superficial vein thrombosis Agenesis of deep vein system Vascular
        malformation or syndrome Post-thrombotic syndrome, occlusive type Pregnancy Phlebectomy on
        the thigh Immobility Allergy to lidocaine Arterial insufficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Denis Borsuk, MD, PhD</last_name>
    <phone>+79630777333</phone>
    <email>borsuk-angio@mail.ru</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinic of Phlebology and Laser Surgery</name>
      <address>
        <city>Chelyabinsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denis Borsuk, MD, PhD</last_name>
      <phone>+79630777333</phone>
      <email>borsuk-angio@mail.ru</email>
    </contact>
    <investigator>
      <last_name>Roman Tauraginskiy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>GarantClinic</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ovsep Mandzhikian, MD, PhD</last_name>
      <phone>+79261076056</phone>
      <email>manjikyan@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <link>
    <url>http://www.venousregistry.org/</url>
    <description>the Russian Registry of Treatment of Chronic Venous Diseases (RRT CVD). ClinicalTrials.gov ID: NCT03035747</description>
  </link>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 29, 2017</study_first_submitted>
  <study_first_submitted_qc>January 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2017</study_first_posted>
  <last_update_submitted>February 1, 2017</last_update_submitted>
  <last_update_submitted_qc>February 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clinic of Phlebology and Laser Surgery, Chelyabinsk, Russia</investigator_affiliation>
    <investigator_full_name>Denis Borsuk</investigator_full_name>
    <investigator_title>Chief surgeon</investigator_title>
  </responsible_party>
  <keyword>endovenous laser ablation</keyword>
  <keyword>radial fiber</keyword>
  <keyword>linear endovenous energy density</keyword>
  <keyword>1470 nm</keyword>
  <keyword>occlusion rate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Veins</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data collection will take place at the Russian Registry of Treatment of Chronic Venous Diseases (RRT CVD). Access to the data will be available after completion of the study. To access the data will need to send a request to RRT CVD administrator. Register in Russian. Registry now listed in the database ClinicalTrials.gov, ID NCT03035747 (see references)</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

